Molecular Characterisation of Colorectal Cancer Peritoneal Metastases: Genomic and Transcriptomic Analysis With Correlation of Clinical Outcomes
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
⁃ Participants are eligible to be included in the study only if all of the following criteria apply:
• Patients ≥ 18 years old who have been diagnosed with colorectal cancer and have colorectal peritoneal metastases,
• have had cytoreductive surgery at the Christie
• have availability of archival tumour tissue (paired CRC and CRPM)
Locations
Other Locations
United Kingdom
Christie Hospital NHS Foundation Trust
RECRUITING
Manchester
Contact Information
Primary
Richa Garvia, Ms
removed_due_to_spam@email.com
0161 446 3000
Time Frame
Start Date: 2024-02-04
Estimated Completion Date: 2025-07-03
Participants
Target number of participants: 200
Treatments
All patients
Colorectal cancer patients
Related Therapeutic Areas
Sponsors
Collaborators: University of Manchester
Leads: The Christie NHS Foundation Trust